METADOS

METADOS

TBA
1,143 Views
MetaDOS - BattleRoyale ESPORT & TOURNAMENT Explore a growing roster of powerful Players, each with their own unique personality, strengths, and abilities. OWN YOUR NFTS Your game items, such as skins and lands, are also your own NFTs. You can trade them or even use them on other games on DOS. SKILL & TIME Master powerful weapons, unique abilities, and your own Time (Your own life).
1.4
TOTAL SCORE
1.9
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
Dates: TBA
Token info
Ticker: METADOS
Platform: Unknown
Financial
Social media
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Active
Rivalz
Rivalz is redefining AI infrastructure by creating an AI Intel Layer to unlock new agentic economies. Built on a dual-chain DePIN architecture using Dymension and Arbitrum, Rivalz addresses one of the biggest bottlenecks in AI today: access to AI-ready, verifiable, and secure data. As we envision the web3 space to become agentic and overtake humans in the amount of transactions over time, what Rivalz is building is key for enabling this future. The core challenge that Rivalz is addressing is the need for AI-ready, verifiable and accessible data and later on intelligence. Rivalz offers a hybrid solution combining decentralized storage and high-speed agent-centric connectivity networks that cater specifically to AI's demands, ushering in the era of the agentic economy.
Active
Origin Protocol
Origin is building a platform that enables the creation of many decentralized marketplaces, allowing buyers and sellers to connect and transact directly on the blockchain. The company is building a set of protocols, developer libraries, and a decentralized application using the Ethereum blockchain and IPFS, with an initial focus on disrupting sharing economy marketplaces. Origin's mission is to reduce or remove transaction fees, promote open and transparent commerce, redistribute value more fairly to buyers and sellers, and empower the 2 billion currently unbanked individuals around the world to participate in digital marketplaces.
Upcoming
Blocklancer
Blocklancer is a so called Distributed Autonomous Job Market (DAJ) on the Ethereum platform, our vision of a completely self-regulatory platform for finding jobs and getting projects done. It will change the way freelancing works, both for customers and freelancers, and it will lift the reliability of freelancing to new heights.
Upcoming
Constellation
The Constellation protocol implements a horizontally scalable blockchain architecture known as Extended Trust Chain with a peer to peer layer known as a gossip protocol that can be deployed on a mobile device. Constellation approaches smart contracts with a microservice architecture allowing for highly available services to be chained and composed into distributed applications with just an understanding of each microservice’s SLA (service level agreement) and/or type signature. This architecture ensures high transaction throughput, allowing for consumer grade distributed applications to be built on Constellation.
Upcoming
Artcoin
The art world is traditionally anything but transparent, and that’s where ArtCoin, an investor-driven collective, creates real change for investors. Guiding users through transactions using cryptocurrencies, ArtCoin enables investors to benefit from the increased security and transparency of the Smart Contracts platforms. By pulling together information that everyday investors normally can’t access, ArtCoin democratizes the art market and acts as a direct liaison between investors and the art industry.
Upcoming
MediLOT
MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.